Latest news
Alteogen signs $365m Hybrozyme licensing deal with pharma company - Pharmaceutical TechnologyPharmaceutical Technology · Thu, 06 Aug 2026 17:23:32 GMTWhat the AstraZeneca-BMS rumors reveal about pharma megamergers - Pharma VoicePharma Voice · Thu, 06 Aug 2026 13:40:22 GMTAlteogen Licenses Subcutaneous Platform to Undisclosed Global Pharma Company in Deal Worth Up to $365 Million - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:10:58 GMTNo deal between AstraZeneca and BMS, senior source insists: Reuters - BioSpaceBioSpace · Wed, 05 Aug 2026 15:07:45 GMTMassive Merger Could Be Biggest Pharma Deal In History - FinimizeFinimize · Mon, 03 Aug 2026 21:41:09 GMTThree pharma deals in one day reshape medtech M&A in 2026 - MarketScaleMarketScale · Mon, 03 Aug 2026 21:33:17 GMTAstraZeneca investors balk at prospect of $400 billion Bristol Myers pharma deal - ReutersReuters · Mon, 03 Aug 2026 18:43:06 GMTCurium strikes up to $8B deal for radiopharma rival Lantheus - Fierce BiotechFierce Biotech · Mon, 03 Aug 2026 18:20:15 GMT